The world is quite a different place than it was 12 months ago. That said, there is light at the end of the tunnel and Valid Insight have continued to innovate in 2020.
Clinical and financial value are drivers for success in the pharma industry. But without efficient, targeted pharmaceutical pricing and adequate contracting schemes, the success of any product is not ensured. Read our blog to learn more about suitable pharmaceutical pricing and contracting schemes, including value-based pricing, which address payer and industry uncertainties.
With a global economic recession expected due to the COVID-19 pandemic, a panel of payers and industry representatives discussed the impact that this will have on pharmaceutical pricing, reimbursement and market access, and strategies to mitigate the impact. Read this Valid Insight blog for a summary of the discussions and market access support.